15th Nov 2007 12:16
International Medical Devices PLC15 November 2007 15 November 2007 International Medical Devices plc ("IMD" or "the Company") SuretyTM needle trial with South Western Ambulance Service International Medical Devices plc (AIM: INT), the medical supply companytargeting the acute care, aged care, and devices markets, announces the firstfeedback from the trial of its SuretyTM needle product with the South WesternAmbulance Service. The initial clinical feedback from the trials of the SuretyTM needle product hasproved to be positive, with the initial eight trialists of the productconcluding that the product's key aims have been met. These aims are: 1. Activated using a one handed technique 2. Does not interfere with normal procedures 3. Mandates use of safety feature 4. Works well in wide variety of situations 5. Reduces needle-stick incidents 6. A clear change occurs when safety feature is activated 7. Operates reliably 8. Exposed sharp is covered after use and prior to disposal 9. Does not need extensive training to be used correctly The manually retractable hypodermic safety needle, which was referred to duringits development phase as 'ClipOn', has been trialled by the South WesternAmbulance service in the UK. The initial deployment is intended to be for usewith the drug Narcan IM, which is primarily used on drug overdose patients. Chris Thomas, CEO said: "This trial is a further step towards deployment of theSuretyTM safe needle product throughout the UK healthcare market. The product'ssafety features are well tested in the frantic, fast-paced environment of anambulance service, and passing this phase of the trial further demonstrates itsvalue to the overall healthcare market." The SuretyTM safe needle was launched yesterday at the MEDICA internationaltrade fair held in Dusseldorf, Germany. MEDICA is one of the largest forums forMedical technology and innovation attracting over 137,000 delegates each year. For further information, contact: International Medical JM Finn Parkgreen CommunicationsDevices Geoff Nash Simon Robinson / Erica NelsonChris Thomas, CEO +44 20 7600 1658 +44 20 7851 7480+44 20 3008 4960 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Intelliam Ai